News

The price for a 5-day course of the antiviral drug remdesivir—which has shown to reduce hospital stays for patients with severe COVID-19 illness—is $2,340. This cost is less than the $5,080 price tag…

The World Health Organization states that AstraZeneca’s COVID-19 vaccine is leading the pack, with Moderna’s version a close second. Developed at Britain’s Oxford University, the AstraZeneca vaccine…

New patients are currently being enrolled in the University of Illinois at Chicago’s second clinical trial to study the drug remdesivir as a treatment for COVID-19.

As case numbers spike across the Sun Belt, the United States Centers for Disease Control and Prevention (CDC) has added to the list of those populations who are at high risk of COVID-19. First, the…

The Small Business Personal Protective Equipment (PPE) Tax Credit Act HR 7216 has been introduced by a bipartisan coalition to provide small businesses with a $25,000 tax credit for purchasing the PPE…

The Americal Dental Association (ADA) and Florida Dental Association (FDA) have decided not to move forward with ADA FDC 2020 as an in-person meeting, originally scheduled for October 15–18 in…

Pulpdent Corporation has launched a mobile-friendly new website for dentists, dental hygienists and other members of the dental industry.

While the United States struggles to contain the COVID-19 pandemic, dentistry continues its recovery, according to a new poll by the American Dental Association Health Policy Institute. Taken during…

The United States Food and Drug Administration recently released a statement advising against the use of hand sanitizer manufactured by Mexico-based Eskbiochem SA de CV.

In today’s episode of The Art of Dental Finance and Management podcast, Art meets with Kristie Boltz, owner of MyDentalCMO, to discuss marketing your dental practice through COVID-19. Through her…